psilocybin - Page 1 | CARLAT PUBLISHING

Expert Q&A

Psychedelics and Addiction

April 1, 2024

Snehal Bhatt, MD.

Chief, Addiction Psychiatry; Professor, Psychiatry and Behavioral Sciences, University of New Mexico, Albuquerque, NM.

Dr. Bhatt has no financial relationships with companies related to this material.

Dr. Bhatt outlines the latest developments in therapeutic uses of psychedelic medications. He highlights the great opportunities as well as the potential drawbacks. He details some of his own work in the use of psilocybin for the treatment of alcohol use disorder and advises clinicians how to discuss psychedelics with their patients.

Psilocybin vs Escitalopram for Depression

September 10, 2021

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psilocybin is inching its way toward FDA approval in depression, but will this trial from the New England Journal of Medicine help it along or set it back?

Psilocybin: The New Holy Grail for the Rapid Relief of Major Depression?

July 14, 2021

Paul Barkopoulos, MD.

Paul Barkopoulos, MD. Dr. Barkopoulos has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Like ketamine, psilocybin works quickly to relieve depression, but it’s not habit-forming and its effects might last longer.

Psilocybin, Ketamine, and the Spiritual Brain

February 4, 2020

A new antidepressant is under development that could change the field even more than esketamine. And even if it doesn't, its novel effects on the mind reveals something that can help our patients today. This fascinating drug was commonly prescribed by psychiatrists in the 1950's until Richard Nixon tried to...